Microbiome Therapeutics

company

About

MicroBiome Therapeutics is a biotechnology company that develops medical food and pharmaceutical products.

  • 1 - 10

Details

Last Funding Type
Series B
Last Funding Money Raised
$1M
Industries
Biotechnology,Health Care,Pharmaceutical,Therapeutics
Founded date
Jan 1, 2009
Number Of Employee
1 - 10
Operating Status
Close

MicroBiome Therapeutics is a biotechnology company that develops medical food and pharmaceutical products. The company focuses on developing evidence-based microbiome modulators, which are designed to alter bacteria populations and their environment in the gastrointestinal tract in specific ways to treat and prevent serious health conditions. Its product includes NM504, which contains a combination of prebiotic and other naturally occurring ingredients formulated to help diabetic individuals achieve healthy blood glucose levels and manage their body weight.

MicroBiome Therapeutics was formerly known as NuMe Health LLC. The company was founded in 2009 and is based in Broomfield, Colorado.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$2.30M
Microbiome Therapeutics has raised a total of $2.30M in funding over 2 rounds. Their latest funding was raised on Nov 1, 2017 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 1, 2017 Series B $1M 1 Detail
Dec 20, 2013 Seed $1.30M 1 BVM Capital Detail

Investors

Number of Lead Investors
Number of Investors
1
2
Microbiome Therapeutics is funded by 2 investors. BVM Capital and Lagniappe Angels are the most recent investors.
Investor Name Lead Investor Funding Round
BVM Capital Yes Seed
Lagniappe Angels Series B